These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: First report of CTX-M-9 in a clinical isolate of Enterobacter cloacae in a Tunisian hospital.
    Author: Bourouis A, Dubois V, Coulange L, André C, Bejhadj C, Ben Moussa M, Quentin C, Belhadj O.
    Journal: Pathol Biol (Paris); 2011 Aug; 59(4):187-91. PubMed ID: 19481370.
    Abstract:
    β-lactamases are one of several mechanisms of bacterial resistance to β-lactam antibiotics. The aim of this study was to analyze the resistance to extended-spectrum cephalosporins of a multidrug-resistant isolate of Enterobacter cloacae, BF5011. This strain was isolated from a stool culture, during the nosocomials infections occurring in the intensive care unit of the Military Hospital of Tunis in 2005. Analysis of E. cloacae BF5011 by double-disk synergy test yielded a positive result suggesting the production of extended-spectrum-β-lactamases. Cell sonicate of this isolate is very active against cefotaxime and showed a specific activity (AS) of 7,54 U/mg for the same antibiotic. This activity was inhibited by the sulbactam and the clavulanic acid. By polymerase chain reaction and sequencing, the isolate was found to produce extended-spectrum-β-lactamase, CTX-M-9. The bla(CTX-M-9) gene was transferred from E. cloacae by conjugation. Isoelectric focusing method revealed one band with a pI of about 8. This is the first report of CTX-M-9 in Tunisia.
    [Abstract] [Full Text] [Related] [New Search]